We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Green Tea Component Battles Sepsis

By HospiMedica staff writers
Posted on 19 Nov 2007
An antioxidant catechin, which is a major constituent of green tea, could help fight severe sepsis, according to a new study. More...


Researchers at The Feinstein Institute for Medical Research (Manhasset, NY, USA) examined the therapeutic powers of dozens of Chinese herbal compounds in an attempt to find a way to block high mobility group box 1 (HMGB1), a chromatin protein expressed in the late stages of lethal sepsis, theorizing that this would prevent the lethal sepsis process from moving forward. Among the substances examined was a substance found in green tea called Epigallocatechin gallate (EGCG), which was given to mice in the throes of severe sepsis caused by cecal ligation and puncture. The dose administered was equivalent to 10 cups of tea in a human being.

The researchers found that intraperitoneal administration of EGCG protected the mice against lethal endotoxemia, and rescued mice from lethal sepsis even when the first dose was given 24 hours after puncture. Survival rate jumped from 53% in those who didn't receive the green tea substance to 82% in those who did. The researchers found that the compound prevented HMGB1 from being released by immune cells, and suppressed HMGB1-mediated inflammatory responses by preventing clustering of exogenous HMGB1 on macrophage cell surface. The study was published online in the November 7, 2007, issue of the Public Library of Science journal ONE (PLoS-ONE).

"Clinically, even if we could save five percent of patients, that would be huge,” said lead author Dr. Haichao Wang, Ph.D. "In this study, we saved 25% more animals with the green tea.”

Catechins are polyphenolic antioxidant plant metabolites present in numerous plant species. The largest source in the human diet is from various teas derived from the tea-plant Camellia Sinensis. Green tea catechins have also been shown to possess antibiotic properties, due to their role in disrupting a specific stage of the bacterial DNA replication process.


Related Links:
The Feinstein Institute for Medical Research

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.